Benitec Biopharma Inc.BNTCNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
16.00%
↑ 149% above average
Average (39q)
-32.58%
Historical baseline
Range
High:268.04%
Low:-690.08%
CAGR
+1.9%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 16.00% |
| Q2 2025 | -72.62% |
| Q1 2025 | -27.14% |
| Q4 2024 | -45.42% |
| Q3 2024 | -7.18% |
| Q2 2024 | -10.31% |
| Q1 2024 | 37.06% |
| Q4 2023 | -14.18% |
| Q3 2023 | -27.74% |
| Q2 2023 | -6.00% |
| Q1 2023 | 18.74% |
| Q4 2022 | -6.24% |
| Q3 2022 | -0.51% |
| Q2 2022 | -54.72% |
| Q1 2022 | 32.07% |
| Q4 2021 | 4.44% |
| Q3 2021 | -26.03% |
| Q2 2021 | -2.40% |
| Q1 2021 | -20.20% |
| Q4 2020 | -19.65% |
| Q3 2020 | 7.39% |
| Q2 2020 | -39.63% |
| Q1 2020 | -0.57% |
| Q4 2019 | -82.21% |
| Q3 2019 | 21.92% |
| Q2 2019 | 13.79% |
| Q1 2019 | -165.86% |
| Q4 2018 | -21.02% |
| Q3 2018 | 268.04% |
| Q2 2018 | 5.83% |
| Q1 2018 | 8.96% |
| Q4 2017 | -0.74% |
| Q3 2017 | -13.56% |
| Q2 2017 | -690.08% |
| Q1 2017 | 90.68% |
| Q4 2016 | -576.95% |
| Q3 2016 | 113.12% |
| Q2 2016 | -73.62% |
| Q1 2016 | 55.77% |
| Q4 2015 | 7.65% |